MBX Biosciences (MBX) Depreciation and Depletion (2023 - 2026)
MBX Biosciences (MBX) reported Depreciation and Depletion of $100000.0 for Q1 2026, up 29.87% on a YoY basis from $77000.0 in Q1 2025, and up 66.67% sequentially from $60000.0 in Q4 2025.
MBX Biosciences (MBX) Depreciation and Depletion (2023 - 2026) Analysis & Trends
MBX Biosciences (MBX) has 4 years of Depreciation and Depletion data on file, last reported at $100000.0 in Q1 2026.
- For the quarter ending Q1 2026, Depreciation and Depletion rose 29.87% year-over-year to $100000.0; the trailing twelve-month figure through Mar 2026 stood at $360000.0 (up 12.15% YoY), and the FY2025 full-year result was $248000.0, up 1.64% from the prior year.
- Depreciation and Depletion rose to $100000.0 in Q1 2026, from $60000.0 in the prior quarter.
- In the past five years, Depreciation and Depletion ranged from a high of $100000.0 in Q3 2023 to a low of $44000.0 in Q4 2024.
- A 4-year average of $83000.0 and a median of $100000.0 in 2023 frame the typical range for Depreciation and Depletion.
- Across the five-year window, Depreciation and Depletion sank 47.62% in 2024 and surged 60.42% in 2025, its largest moves.
- Tracing MBX's Depreciation and Depletion over 4 years: stood at $84000.0 in 2023, then slumped by 47.62% to $44000.0 in 2024, then soared by 36.36% to $60000.0 in 2025, then soared by 66.67% to $100000.0 in 2026.
- Business Quant data shows MBX's Depreciation and Depletion at $100000.0 in Q1 2026, $60000.0 in Q4 2025, and $100000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Depreciation and Depletion (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | 196,658.72 |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 39.39 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | - |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | - |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | 2.20 Mn |
| 10 | MBX Biosciences | 2.96 Bn | 2.96 Bn | - | 100,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 100,000.00 |
| Mar 31, 2026 | 100,000.00 |
| Dec 31, 2025 | 60,000.00 |
| Dec 31, 2025 | 60,000.00 |
| Sep 30, 2025 | 100,000.00 |
| Sep 30, 2025 | 100,000.00 |
| Jun 30, 2025 | 100,000.00 |
| Jun 30, 2025 | 100,000.00 |
| Mar 31, 2025 | 77,000.00 |
| Mar 31, 2025 | 77,000.00 |
| Dec 31, 2024 | 44,000.00 |
| Dec 31, 2024 | 44,000.00 |
| Sep 30, 2024 | 100,000.00 |
| Sep 30, 2024 | 100,000.00 |
| Jun 30, 2024 | 100,000.00 |
| Jun 30, 2024 | 100,000.00 |
| Mar 31, 2024 | 48,000.00 |
| Mar 31, 2024 | 48,000.00 |
| Dec 31, 2023 | 84,000.00 |
| Dec 31, 2023 | 84,000.00 |